α2β1 Integrin Ligand Peptide

The DGEA peptide, derived from type I collagen, acts as an α2β1 integrin receptor antagonist by mimicking its native binding sequence. This small molecule is utilized in vitro and in vivo to study integrin-mediated cell adhesion, signaling, and collagen receptor function in research areas such as cancer metastasis and angiogenesis.